ERAS Erasca, Inc.
Healthcare$11.50+2.31%ClosedMarket Cap: $3.58B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
8.69
P/S
0.00
EV/EBITDA
-27.14
DCF Value
$0.10
FCF Yield
-2.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-77.0%
ROA
-60.1%
ROIC
-32.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-37.9M | $-183.4M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-32.6M | $-29.1M | $— | — |
| FY null | $0.00 | -Infinity% | $-131.4M | $-124.5M | $— | — |
| Q3 null | $0.00 | NaN% | $-34.5M | $-30.6M | $— | — |
| Q2 null | $0.00 | NaN% | $-38.1M | $-33.9M | $— | — |
| Q1 null | $0.00 | NaN% | $-35.6M | $-31.0M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-35.7M | $-32.2M | $— | — |
| FY null | $0.00 | NaN% | $-179.6M | $-161.7M | $— | — |
| Q3 null | $0.00 | NaN% | $-37.2M | $-31.2M | $— | — |
| Q2 null | $0.00 | NaN% | $-67.8M | $-63.2M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-38.9M | $-35.0M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-33.9M | $-29.7M | $-0.20 | — |